RCS - ZAGENO - ZAGENO Secures $33M Funding

AirbnbAnnouncement

25/05/2023 14:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230525:nRSY5775Aa&default-theme=true

RNS Number : 5775A  ZAGENO  25 May 2023

ZAGENO Secures $33M Funding to Revolutionize Life Science Research Procurement

ZAGENO Empowers Life Science Research with Unparalleled Efficiency and Cost
Savings

CAMBRIDGE, MA / ACCESSWIRE / May 25, 2023 / ZAGENO, the leading online
marketplace for life science research products, announces the completion of a
$33 million funding round. General Catalyst, the largest public pension fund
in the United States, Grazia Equity, OakRidge Management Group, and a German
investment house led this round, joined by existing investors Capnamic
Ventures and HighSage Ventures.

Logo

This funding propels ZAGENO's expansion in the United States and Europe,
significantly enhancing the accessibility and affordability of life science
research products. ZAGENO simplifies product discovery, experiment planning,
and seamless purchasing from thousands of suppliers. The marketplace
revolutionizes the scientific workflow, saving time and product costs. With a
wide selection of quality products and verified suppliers, scientists benefit
from competitive pricing fostered by the marketplace's transparency and
supplier choice.

"We're thrilled to welcome new investors, including one of America's most
powerful shareholder bodies and global leader in the investment industry and a
prominent German investment house, while enjoying continued support from
General Catalyst and existing investors," said Florian Wegener, CEO of ZAGENO.
"This funding empowers scientists to focus on scientific value creation."

ZAGENO's online marketplace offers a vast selection of products and services,
including laboratory equipment, consumables, chemicals, antibodies, and
customized solutions. By providing scientists access to a network of verified
suppliers, the ZAGENO platform enables informed purchasing decisions.

"ZAGENO is transforming the scientific research industry with its
groundbreaking platform," said Larry Bohn, Managing Partner at General
Catalyst. "We proudly support their journey."

"With this funding, ZAGENO is positioned to deliver even greater value to
scientists worldwide," emphasized Joe von Rickenbach, Chairman of the Board of
ZAGENO. "Their innovative platform drives unmatched efficiency and cost
savings."

ZAGENO is primed for rapid growth and pioneering innovation in the scientific
research industry with this new funding.

To learn more about ZAGENO, please visit www.zageno.com
(https://pr.report/Sink7R5G) .

About ZAGENO

ZAGENO is a marketplace for life science research products. By revolutionizing
how scientists discover, procure, and manage life science research products,
ZAGENO supports researchers pursuing breakthroughs that improve our lives.
With an extensive catalog, advanced search functionality, transparent pricing,
and dedicated customer support, ZAGENO simplifies the research workflow and
enables scientists to focus on groundbreaking discoveries. ZAGENO is a global
company with offices in Cambridge, San Francisco, Berlin, and Bangalore. For
more information, visit www.zageno.com (https://pr.report/cYqnj3dg) .

About General Catalyst

General Catalyst is a venture capital firm that invests in powerful, positive
change that endures - for our entrepreneurs, our investors, our people, and
society. We support founders with a long-term view who challenge the status
quo, partnering with them from seed to growth stage and beyond to build
companies that withstand the test of time. With offices in San Francisco, Palo
Alto, New York City, London, and Boston, the firm has helped support the
growth of businesses such as: Airbnb, Deliveroo, Guild, Gusto, Hubspot,
Illumio, Lemonade, Livongo, Oscar, Samsara, Snap, Stripe, and Warby Parker.
For more: www.generalcatalyst.com (https://pr.report/tL-3XF7G) .

Contact Information

Stephanie Harold
pr@zageno.com (mailto:pr@zageno.com)

+1 (857) 477-8479

Related Files

ZAGENO.png (https://pr.report/4cIN3PuK)

Related Images

 

 

SOURCE: ZAGENO

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRASESFULEDSELI